Determinants of progressive renal disease in diabetes mellitus

Author(s): Aurell M, Bjorck S

Abstract

The prognosis for the patient with diabetic nephropathy has improved considerably during the last decade. This is due to identification and treatment of different risk factors. Elevated blood pressure has turned out to be a major risk factor in established diabetic nephropathy. The impact of metabolic control has also been demonstrated. Lipid abnormalities have recently been identified as a possible factor that accelerates loss of renal function. The role of renal hemodynamic alterations is probably also important. Their contribution can indirectly be assessed by studying the effects of pharmacologic therapy. Angiotension converting enzyme inhibitors reduce proteinuria by a mechanism independent of systemic blood pressure and there is suggestive evidence that they preserve renal function to a greater degree than other antihypertensive agents.

Similar Articles

Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes

Author(s): Carroll MF, Gutierrez A, Castro M, Tsewang D, Schade DS

Chemistry and biochemistry of type 2 diabetes

Author(s): Ross SA, Gulve EA, Wang M

Medicinal plants of India with anti-diabetic potential

Author(s): Grover JK, Yadav S, Vats V

Antidiarrhoeal activity of Acacia nilotica Willd

Author(s): Misar A, Bhagat R, Mujumdar AM

Antioxidant and anti-quorum sensing activities of green pod of Acacia nilotica L

Author(s): Singh BN, Singh BR, Singh RL, Prakash D, Sarma BK, et al.

In vitro survey of alpha-glucosidase inhibitory food components

Author(s): Matsui T, Yoshimoto C, Osajima K, Oki T, Osajima Y

Antidiabetic principles of natural medicines

Author(s): Matsuda H, Murakami T, Yashiro K, Yamahara J, Yoshikawa M

Kinetic and structural characterization of the glutathione-binding site of Aldose reductase

Author(s): Dixit BL, Balendiran GK, Watowich SJ, Srivastava S, Ramana KV, et al.

Characterization of the glutathione binding site of aldose reductase

Author(s): Ramana KV, Dixit BL, Srivastava S, Bhatnagar A, Balendiran GK, et al.